Corporate entities operating under specialized holding structures or distinct regional names typically outline dividend policies based on operational cash flow generation and capital expenditure requirements. For clinical-stage enterprises like Alector, the policy remains focused entirely on retaining earnings to fund research and clinical pipelines rather than paying cash dividends. For other unrelated holding structures bearing similar acronyms, dividend distribution schedules depend strictly on their respective board resolutions and underlying sector profitability.